TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9263804
log Bayes Factor = 56.144
Chromosome 6   position 31,135,706  (GRCh37) Explore rs9263804 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E11.9 Without complications
0.000 0.000 1.000
E83.1 Disorders of iron metabolism
0.999 0.001 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.001 0.999
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.008 0.992
E05.9 Thyrotoxicosis, unspecified
0.000 0.008 0.992
E78.0 Pure hypercholesterolaemia
0.000 0.012 0.988
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.015 0.985
E70-E90 Metabolic disorders
0.000 0.019 0.981
L40 Psoriasis
0.000 0.036 0.964
E14 Unspecified diabetes mellitus
0.000 0.045 0.955
G35 Multiple sclerosis
0.954 0.046 0.000
L40.5 Arthropathic psoriasis
0.000 0.090 0.910
E11.0 With coma
0.000 0.136 0.864
E14.3 With ophthalmic complications
0.000 0.143 0.857
E78.8 Other disorders of lipoprotein metabolism
0.000 0.145 0.855
E10.3 With ophthalmic complications
0.000 0.147 0.853
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.162 0.838
E14.9 Without complications
0.000 0.163 0.837
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.169 0.831
E07 Other disorders of thyroid
0.000 0.170 0.830
E11.1 With ketoacidosis
0.000 0.171 0.829
E78.2 Mixed hyperlipidaemia
0.000 0.178 0.822
L40.0 Psoriasis vulgaris
0.000 0.181 0.819
L40.8 Other psoriasis
0.000 0.192 0.808
E03.8 Other specified hypothyroidism
0.000 0.194 0.806
E74 Other disorders of carbohydrate metabolism
0.000 0.202 0.798
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.209 0.791
E79 Disorders of purine and pyrimidine metabolism
0.000 0.232 0.768
E10.6 With other specified complications
0.000 0.245 0.755
E14.5 With peripheral circulatory complications
0.000 0.247 0.753
E10.8 With unspecified complications
0.000 0.248 0.752
E11.2 With renal complications
0.000 0.250 0.749
E78.1 Pure hyperglyceridaemia
0.000 0.253 0.747
E13 Other specified diabetes mellitus
0.000 0.261 0.739
L40.1 Generalised pustular psoriasis
0.000 0.264 0.736
K90 Intestinal malabsorption
0.000 0.277 0.723
E07.9 Disorder of thyroid, unspecified
0.000 0.279 0.721
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
E11.7 With multiple complications
0.000 0.284 0.716
E10.1 With ketoacidosis
0.000 0.285 0.715
E14.4 With neurological complications
0.000 0.288 0.712
E05.5 Thyroid crisis or storm
0.000 0.288 0.712
E05.4 Thyrotoxicosis factitia
0.000 0.288 0.712
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.288 0.712
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.288 0.712
E10.0 With coma
0.000 0.289 0.711
E78.4 Other hyperlipidaemia
0.000 0.290 0.710
E40-E46 Malnutrition
0.000 0.292 0.708
E78.6 Lipoprotein deficiency
0.000 0.292 0.708
E78.3 Hyperchylomicronaemia
0.000 0.294 0.706
E77 Disorders of glycoprotein metabolism
0.000 0.296 0.704
E76 Disorders of glycosaminoglycan metabolism
0.000 0.296 0.704
E72 Other disorders of amino-acid metabolism
0.000 0.296 0.704
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.296 0.704
E70 Disorders of aromatic amino-acid metabolism
0.000 0.296 0.704
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.296 0.704
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.304 0.695
L40.2 Acrodermatitis continua
0.000 0.309 0.691
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.309 0.691
E14.6 With other specified complications
0.000 0.311 0.689
E14.1 With ketoacidosis
0.000 0.312 0.688
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.312 0.688
G35-G37 Demyelinating diseases of the central nervous system
0.686 0.314 0.000
L40.4 Guttate psoriasis
0.000 0.315 0.685
E14.7 With multiple complications
0.000 0.315 0.684
E14.0 With coma
0.000 0.315 0.684
E83 Disorders of mineral metabolism
0.648 0.319 0.033
E84 Cystic fibrosis
0.000 0.322 0.678
E14.2 Withrenal complications
0.000 0.322 0.678
E80.4 Gilbert's syndrome
0.000 0.337 0.663
E80.6 Other disorders of bilirubin metabolism
0.000 0.346 0.654
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.355 0.645
E14.8 With unspecified complications
0.000 0.356 0.644
E16 Other disorders of pancreatic internal secretion
0.000 0.358 0.642
E80.2 Other porphyria
0.000 0.365 0.635
E03.1 Congenital hypothyroidism without goitre
0.000 0.366 0.634
E11.8 With unspecified complications
0.000 0.372 0.627
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.373 0.627
E78.5 Hyperlipidaemia, unspecified
0.000 0.373 0.627
M06.9 Rheumatoid arthritis, unspecified
0.000 0.376 0.624
G37 Other demyelinating diseases of central nervous system
0.620 0.380 0.000
E10.2 With renal complications
0.000 0.382 0.618
L40-L45 Papulosquamous disorders
0.000 0.384 0.616
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.385 0.615
E10.5 With peripheral circulatory complications
0.000 0.391 0.609
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.404 0.596
E80.5 Crigler-Najjar syndrome
0.000 0.404 0.596
E80.3 Defects of catalase and peroxydase
0.000 0.404 0.596
E80.0 Hereditary erythropoietic porphyria
0.000 0.404 0.596
E07.1 Dyshormogenetic goitre
0.000 0.405 0.595
E07.0 Hypersecretion of calcitonin
0.000 0.405 0.595
E05.8 Other thyrotoxicosis
0.000 0.409 0.591
E80.1 Porphyria cutanea tarda
0.000 0.409 0.591
C83.3 Large cell (diffuse)
0.000 0.413 0.587
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.416 0.584
E88 Other metabolic disorders
0.000 0.418 0.582
K90.9 Intestinal malabsorption, unspecified
0.000 0.422 0.578
E13.9 Without complications
0.000 0.427 0.573
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.428 0.572
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.428 0.572
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.428 0.572
E74.2 Disorders of galactose metabolism
0.000 0.428 0.572
E74.1 Disorders of fructose metabolism
0.000 0.428 0.572
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.429 0.571
E73 Lactose intolerance
0.000 0.431 0.569
E07.8 Other specified disorders of thyroid
0.000 0.431 0.569
E83.3 Disorders of phosphorus metabolism
0.558 0.432 0.009
E15 Nondiabetic hypoglycaemic coma
0.000 0.432 0.567
L40.3 Pustulosis palmaris et plantaris
0.000 0.433 0.567
G37.9 Demyelinating disease of central nervous system, unspecified
0.565 0.435 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.449 0.551
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.449 0.551
E79.1 Lesch-Nyhan syndrome
0.000 0.449 0.551
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.452 0.547
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.468 0.532
E13.8 With unspecified complications
0.000 0.470 0.530
E13.7 With multiple complications
0.000 0.470 0.530
E13.6 With other specified complications
0.000 0.470 0.530
E13.5 With peripheral circulatory complications
0.000 0.470 0.530
E13.4 With neurological complications
0.000 0.470 0.530
E13.2 With renal complications
0.000 0.470 0.530
E13.1 With ketoacidosis
0.000 0.470 0.530
E13.0 With coma
0.000 0.470 0.530
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.473 0.527
G36 Other acute disseminated demyelination
0.527 0.473 0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.474 0.526
L43 Lichen planus
0.000 0.475 0.525
E83.9 Disorder of mineral metabolism, unspecified
0.502 0.477 0.021
K90.3 Pancreatic steatorrhoea
0.000 0.481 0.518
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.481 0.518
K90.1 Tropical sprue
0.000 0.481 0.518
E11.5 With peripheral circulatory complications
0.000 0.483 0.517
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E16.2 Hypoglycaemia, unspecified
0.000 0.487 0.513
E10.4 With neurological complications
0.000 0.487 0.513
E74.0 Glycogen storage disease
0.000 0.491 0.509
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.492 0.508
E45 Retarded development following protein-energy malnutrition
0.000 0.492 0.508
E43 Unspecified severe protein-energy malnutrition
0.000 0.492 0.508
E42 Marasmic kwashiorkor
0.000 0.492 0.508
E41 Nutritional marasmus
0.000 0.492 0.508
E40 Kwashiorkor
0.000 0.492 0.508
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.495 0.504
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.495 0.504
E70.3 Albinism
0.000 0.495 0.504
E70.2 Disorders of tyrosine metabolism
0.000 0.495 0.504
E70.1 Other hyperphenylalaninaemias
0.000 0.495 0.504
E70.0 Classical phenylketonuria
0.000 0.495 0.504
E71.3 Disorders of fatty-acid metabolism
0.000 0.495 0.504
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.495 0.504
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.495 0.504
E71.0 Maple-syrup-urine disease
0.000 0.495 0.504
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.495 0.504
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.495 0.504
E72.5 Disorders of glycine metabolism
0.000 0.495 0.504
E72.4 Disorders of ornithine metabolism
0.000 0.495 0.504
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.495 0.504
E72.2 Disorders of urea cycle metabolism
0.000 0.495 0.504
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.495 0.504
E72.0 Disorders of amino-acid transport
0.000 0.495 0.504
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.495 0.504
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.495 0.504
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.495 0.504
E76.2 Other mucopolysaccharidoses
0.000 0.495 0.504
E76.1 Mucopolysaccharidosis, type II
0.000 0.495 0.504
E76.0 Mucopolysaccharidosis, type I
0.000 0.495 0.504
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.495 0.504
E77.8 Other disorders of glycoprotein metabolism
0.000 0.495 0.504
E77.1 Defects in glycoprotein degradation
0.000 0.495 0.504
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.495 0.504
E13.3 With ophthalmic complications
0.000 0.497 0.503
E16.1 Other hypoglycaemia
0.000 0.498 0.502
E46 Unspecified protein-energy malnutrition
0.000 0.501 0.499
G37.8 Other specified demyelinating diseases of central nervous system
0.499 0.501 0.000
K90.8 Other intestinal malabsorption
0.000 0.502 0.498
E75.6 Lipid storage disorder, unspecified
0.000 0.507 0.493
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.507 0.493
E75.3 Sphingolipidosis, unspecified
0.000 0.507 0.493
E75.2 Other sphingolipidosis
0.000 0.507 0.493
E75.1 Other gangliosidosis
0.000 0.507 0.493
E75.0 GM2 gangliosidosis
0.000 0.507 0.493
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.510 0.490
E83.8 Other disorders of mineral metabolism
0.465 0.511 0.024
E83.2 Disorders of zinc metabolism
0.465 0.511 0.024
E83.0 Disorders of copper metabolism
0.465 0.511 0.024
E84.8 Cystic fibrosis with other manifestations
0.000 0.514 0.486
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.514 0.486
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.514 0.486
L43.9 Lichen planus, unspecified
0.000 0.518 0.482
L42 Pityriasis rosea
0.000 0.519 0.481
E75.5 Other lipid storage disorders
0.000 0.523 0.477
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.532 0.468
E11.6 With other specified complications
0.000 0.532 0.468
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.539 0.460
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.539 0.460
E16.4 Abnormal secretion of gastrin
0.000 0.539 0.460
E16.3 Increased secretion of glucagon
0.000 0.539 0.460
E84.9 Cystic fibrosis, unspecified
0.000 0.540 0.460
E11.4 With neurological complications
0.000 0.542 0.458
E88.2 Lipomatosis, not elsewhere classified
0.000 0.544 0.455
C83 Diffuse non-Hodgkin's lymphoma
0.004 0.544 0.451
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.001 0.546 0.454
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.553 0.447
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.553 0.447
C85.1 B-cell lymphoma, unspecified
0.000 0.554 0.446
G37.5 Concentric sclerosis [Balo]
0.444 0.555 0.000
G37.4 Subacute necrotising myelitis
0.444 0.555 0.000
G37.2 Central pontine myelinolysis
0.444 0.555 0.000
G37.1 Central demyelination of corpus callosum
0.444 0.555 0.000
G37.0 Diffuse sclerosis
0.444 0.555 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.006 0.557 0.438
L44 Other papulosquamous disorders
0.000 0.558 0.442
L41 Parapsoriasis
0.000 0.558 0.442
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.558 0.442
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.565 0.435
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.567 0.432
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.002 0.570 0.428
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.573 0.427
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.575 0.424
E88.9 Metabolic disorder, unspecified
0.000 0.582 0.417
E88.8 Other specified metabolic disorders
0.000 0.582 0.417
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.583 0.417
E88.3 Tumour lysis syndrome
0.000 0.587 0.413
G36.0 Neuromyelitis optica [Devic]
0.412 0.588 0.000
E73.8 Other lactose intolerance
0.000 0.592 0.408
E73.1 Secondary lactase deficiency
0.000 0.592 0.408
E73.0 Congenital lactase deficiency
0.000 0.592 0.408
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.596 0.404
E89.4 Postprocedural ovarian failure
0.000 0.598 0.402
E85 Amyloidosis
0.001 0.599 0.400
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.397 0.603 0.000
E06 Thyroiditis
0.000 0.620 0.380
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.622 0.378
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.622 0.378
E89.5 Postprocedural testicular hypofunction
0.000 0.622 0.378
E89.1 Postprocedural hypoinsulinaemia
0.000 0.622 0.378
G36.9 Acute disseminated demyelination, unspecified
0.378 0.622 0.000
G36.8 Other specified acute disseminated demyelination
0.378 0.622 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.378 0.622 0.000
L43.3 Subacute (active) lichen planus
0.000 0.623 0.376
L43.2 Lichenoid drug reaction
0.000 0.623 0.376
L43.1 Bullous lichen planus
0.000 0.623 0.376
L43.0 Hypertrophic lichen planus
0.000 0.623 0.376
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.623 0.376
E44.1 Mild protein-energy malnutrition
0.000 0.636 0.364
E44.0 Moderate protein-energy malnutrition
0.000 0.636 0.364
E89.3 Postprocedural hypopituitarism
0.000 0.636 0.364
E83.4 Disorders of magnesium metabolism
0.352 0.636 0.012
C83.7 Burkitt's tumour
0.003 0.648 0.349
C82.2 Large cell, follicular
0.001 0.653 0.346
E65-E68 Obesity and other hyperalimentation
0.000 0.661 0.338
C82.3 Follicular lymphoma grade IIIa
0.001 0.667 0.332
C81 Hodgkin's disease
0.003 0.673 0.324
C83.6 Undifferentiated (diffuse)
0.003 0.673 0.324
C83.5 Lymphoblastic (diffuse)
0.003 0.673 0.324
C83.4 Immunoblastic (diffuse)
0.003 0.673 0.324
C83.2 Mixed small and large cell (diffuse)
0.003 0.673 0.324
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.001 0.674 0.325
C85.0 Lymphosarcoma
0.001 0.674 0.325
E89.2 Postprocedural hypoparathyroidism
0.000 0.680 0.320
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.004 0.682 0.314
C86 Other specified types of T/NK-cell lymphoma
0.004 0.682 0.314
L41.9 Parapsoriasis, unspecified
0.000 0.683 0.317
L41.8 Other parapsoriasis
0.000 0.683 0.317
L41.5 Retiform parapsoriasis
0.000 0.683 0.317
L41.4 Large plaque parapsoriasis
0.000 0.683 0.317
L41.3 Small plaque parapsoriasis
0.000 0.683 0.317
L41.2 Lymphomatoid papulosis
0.000 0.683 0.317
L41.1 Pityriasis lichenoides chronica
0.000 0.683 0.317
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.683 0.317
L44.9 Papulosquamous disorder, unspecified
0.000 0.683 0.317
L44.8 Other specified papulosquamous disorders
0.000 0.683 0.317
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.683 0.317
L44.3 Lichen ruber moniliformis
0.000 0.683 0.317
L44.2 Lichen striatus
0.000 0.683 0.317
L44.1 Lichen nitidus
0.000 0.683 0.317
L44.0 Pityriasis rubra pilaris
0.000 0.683 0.317
C84 Peripheral and cutaneous T-cell lymphomas
0.003 0.684 0.313
C85.7 Other specified types of non-Hodgkin's lymphoma
0.001 0.684 0.316
C82.6 Cutaneous follicle centre lymphoma
0.001 0.691 0.307
C82.5 Diffuse follicle centre lymphoma
0.001 0.691 0.307
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.001 0.692 0.307
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.003 0.697 0.300
L43.8 Other lichen planus
0.000 0.699 0.301
E83.5 Disorders of calcium metabolism
0.295 0.701 0.004
C82.0 Small cleaved cell, follicular
0.001 0.705 0.293
E20-E35 Disorders of other endocrine glands
0.000 0.706 0.294
C94 Other leukaemias of specified cell type
0.005 0.709 0.287
E85.2 Heredofamilial amyloidosis, unspecified
0.001 0.713 0.287
E85.1 Neuropathic heredofamilial amyloidosis
0.001 0.713 0.287
E85.0 Nonneuropathic heredofamilial amyloidosis
0.001 0.713 0.287
C82.4 Follicular lymphoma grade IIIb
0.001 0.714 0.285
M06 Other rheumatoid arthritis
0.000 0.715 0.285
C81.9 Hodgkin's disease, unspecified
0.001 0.720 0.279
E73.9 Lactose intolerance, unspecified
0.001 0.726 0.273
E85.8 Other amyloidosis
0.001 0.727 0.273
E06.5 Other chronic thyroiditis
0.000 0.727 0.272
E06.4 Drug-induced thyroiditis
0.000 0.727 0.272
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.727 0.272
E06.0 Acute thyroiditis
0.000 0.727 0.272
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.728 0.272
C93 Monocytic leukaemia
0.005 0.729 0.266
C83.1 Small cleaved cell (diffuse)
0.003 0.738 0.258
E50-E64 Other nutritional deficiencies
0.000 0.740 0.260
E28 Ovarian dysfunction
0.000 0.740 0.260
E06.1 Subacute thyroiditis
0.001 0.741 0.259
E85.9 Amyloidosis, unspecified
0.001 0.742 0.257
C91 Lymphoid leukaemia
0.003 0.750 0.247
K91.4 Colostomy and enterostomy malfunction
0.249 0.751 0.000
C88 Malignant immunoproliferative diseases
0.005 0.752 0.243
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.752 0.248
M06.3 Rheumatoid nodule
0.000 0.754 0.246
E28.2 Polycystic ovarian syndrome
0.000 0.755 0.245
E67 Other hyperalimentation
0.000 0.757 0.243
E68 Sequelae of hyperalimentation
0.000 0.757 0.243
E24 Cushing's syndrome
0.000 0.763 0.237
C84.5 Other and unspecified T-cell lymphomas
0.002 0.764 0.234
E23 Hypofunction and other disorders of pituitary gland
0.000 0.765 0.235
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.002 0.765 0.233
C81.3 Lymphocytic depletion
0.002 0.765 0.233
C81.2 Mixed cellularity
0.002 0.765 0.233
C81.7 Other Hodgkin's disease
0.002 0.767 0.230
E85.4 Organ-limited amyloidosis
0.001 0.768 0.232
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.003 0.772 0.225
C86.5 Angioimmunoblastic T-cell lymphoma
0.003 0.772 0.225
C86.4 Blastic NK-cell lymphoma
0.003 0.772 0.225
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.003 0.772 0.225
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.003 0.772 0.225
C86.1 Hepatosplenic T-cell lymphoma
0.003 0.772 0.225
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.003 0.772 0.225
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.003 0.772 0.225
C96.8 Histiocytic sarcoma
0.003 0.772 0.225
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.003 0.772 0.225
C96.6 Unifocal Langerhans-cell histiocytosis
0.003 0.772 0.225
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.003 0.772 0.225
C96.4 Sarcoma of dendritic cells (accessory cells)
0.003 0.772 0.225
C96.3 True histiocytic lymphoma
0.003 0.772 0.225
C96.2 Malignant mast cell tumour
0.003 0.772 0.225
C96.1 Malignant histiocytosis
0.003 0.772 0.225
C96.0 Letterer-Siwe disease
0.003 0.772 0.225
C84.0 Mycosis fungoides
0.002 0.772 0.225
C84.9 Mature T/NK-cell lymphoma, unspecified
0.002 0.773 0.225
C84.8 Cutaneous T-cell lymphoma, unspecified
0.002 0.773 0.225
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.002 0.773 0.225
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.002 0.773 0.225
C84.3 Lymphoepithelioid lymphoma
0.002 0.773 0.225
C84.2 T-zone lymphoma
0.002 0.773 0.225
C84.1 Sezary's diease
0.002 0.773 0.225
C81.0 Lymphocytic predominance
0.002 0.774 0.224
C91.9 Lymphoid leukaemia, unspecified
0.001 0.777 0.222
C82.1 Mixed small cleaved and large cell, follicular
0.002 0.778 0.220
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.778 0.222
E11.3 With ophthalmic complications
0.000 0.782 0.218
C84.4 Peripheral T-cell lymphoma
0.002 0.785 0.213
C95 Leukaemia of unspecified cell type
0.005 0.789 0.206
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.789 0.211
E32 Diseases of thymus
0.000 0.789 0.211
E31 Polyglandular dysfunction
0.000 0.789 0.211
E30 Disorders of puberty, not elsewhere classified
0.000 0.789 0.211
E25 Adrenogenital disorders
0.000 0.789 0.211
C94.7 Other specified leukaemias
0.003 0.791 0.206
C94.5 Acute myelofibrosis
0.003 0.791 0.206
C94.4 Acute panmyelosis
0.003 0.791 0.206
C94.3 Mast cell leukaemia
0.003 0.791 0.206
C94.2 Acute megakaryoblastic leukaemia
0.003 0.791 0.206
C94.1 Chronic erythraemia
0.003 0.791 0.206
C94.0 Acute erythraemia and erythroleukaemia
0.003 0.791 0.206
M06.32 Rheumatoid nodule (Upper arm)
0.000 0.792 0.208
M06.34 Rheumatoid nodule (Hand)
0.000 0.795 0.205
M06.4 Inflammatory polyarthropathy
0.000 0.795 0.205
M06.2 Rheumatoid bursitis
0.000 0.795 0.205
M06.1 Adult-onset Still's disease
0.000 0.795 0.205
E85.3 Secondary systemic amyloidosis
0.001 0.796 0.203
M06.8 Other specified rheumatoid arthritis
0.000 0.799 0.200
E21.3 Hyperparathyroidism, unspecified
0.000 0.805 0.195
C93.9 Monocytic leukaemia, unspecified
0.004 0.805 0.191
C93.7 Other monocytic leukaemia
0.004 0.805 0.191
C93.3 Juvenile myelomonocytic leukaemia
0.004 0.805 0.191
C93.2 Subacute monocytic leukaemia
0.004 0.805 0.191
C93.0 Acute monocytic leukaemia
0.004 0.805 0.191
E23.7 Disorder of pituitary gland, unspecified
0.000 0.808 0.192
E24.2 Drug-induced Cushing's syndrome
0.000 0.810 0.190
E26 Hyperaldosteronism
0.000 0.812 0.187
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.813 0.186
E63 Other nutritional deficiencies
0.000 0.813 0.186
E50 Vitamin A deficiency
0.000 0.813 0.186
E60 Dietary zinc deficiency
0.000 0.813 0.186
E59 Dietary selenium deficiency
0.000 0.813 0.186
E54 Ascorbic acid deficiency
0.000 0.813 0.186
E52 Niacin deficiency [pellagra]
0.000 0.813 0.186
E28.9 Ovarian dysfunction, unspecified
0.000 0.813 0.186
E28.8 Other ovarian dysfunction
0.000 0.813 0.186
E28.1 Androgen excess
0.000 0.813 0.186
E28.0 Oestrogen excess
0.000 0.813 0.186
E23.2 Diabetes insipidus
0.000 0.813 0.187
E56 Other vitamin deficiencies
0.000 0.817 0.183
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.004 0.817 0.179
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.004 0.818 0.178
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.003 0.819 0.178
C91.5 Adult T-cell leukaemia
0.002 0.819 0.179
C83.0 Small cell (diffuse)
0.004 0.819 0.177
E58 Dietary calcium deficiency
0.000 0.819 0.180
C81.1 Nodular sclerosis
0.003 0.820 0.178
C91.8 Mature B-cell leukaemia Burkitt-type
0.002 0.820 0.177
C91.7 Other lymphoid leukaemia
0.002 0.820 0.177
C91.6 Prolymphocytic leukaemia of T-cell type
0.002 0.820 0.177
C91.3 Prolymphocytic leukaemia
0.002 0.820 0.177
C91.2 Subacute lymphocytic leukaemia
0.002 0.820 0.177
E24.9 Cushing's syndrome, unspecified
0.000 0.820 0.179
C88.9 Malignant immunoproliferative disease, unspecified
0.004 0.822 0.174
C88.7 Other malignant immunoproliferative diseases
0.004 0.822 0.174
C88.3 Immunoproliferative small intestinal disease
0.004 0.822 0.174
C88.2 Gamma heavy chain disease
0.004 0.822 0.174
C88.1 Alpha heavy chain disease
0.004 0.822 0.174
E65 Localised adiposity
0.000 0.822 0.178
M06.39 Rheumatoid nodule (Site unspecified)
0.000 0.823 0.176
M06.38 Rheumatoid nodule (Other)
0.000 0.823 0.176
M06.36 Rheumatoid nodule (Lower leg)
0.000 0.823 0.176
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.000 0.823 0.176
M06.33 Rheumatoid nodule (Forearm)
0.000 0.823 0.176
M06.31 Rheumatoid nodule (Shoulder region)
0.000 0.823 0.176
E06.3 Autoimmune thyroiditis
0.000 0.824 0.176
M06.37 Rheumatoid nodule (Ankle and foot)
0.000 0.825 0.175
E51 Thiamine deficiency
0.000 0.825 0.174
E67.8 Other specified hyperalimentation
0.000 0.826 0.174
E67.3 Hypervitaminosis D
0.000 0.826 0.174
E67.2 Megavitamin-B6 syndrome
0.000 0.826 0.174
E67.1 Hypercarotenaemia
0.000 0.826 0.174
E67.0 Hypervitaminosis A
0.000 0.826 0.174
E20 Hypoparathyroidism
0.000 0.827 0.173
E06.9 Thyroiditis, unspecified
0.001 0.829 0.170
E24.8 Other Cushing's syndrome
0.000 0.830 0.170
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.830 0.170
E24.3 Ectopic ACTH syndrome
0.000 0.830 0.170
E24.1 Nelson's syndrome
0.000 0.830 0.170
E24.0 Pituitary-dependent Cushing's disease
0.000 0.830 0.170
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.831 0.169
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.831 0.169
E23.1 Drug-induced hypopituitarism
0.000 0.831 0.169
C92 Myeloid leukaemia
0.005 0.834 0.161
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.000 0.836 0.164
E23.6 Other disorders of pituitary gland
0.000 0.836 0.164
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.837 0.163
C91.0 Acute lymphoblastic leukaemia
0.002 0.840 0.158
M06.30 Rheumatoid nodule (Multiple sites)
0.000 0.840 0.160
E61 Deficiency of other nutrient elements
0.000 0.840 0.160
E29 Testicular dysfunction
0.000 0.840 0.159
E21.4 Other specified disorders of parathyroid gland
0.000 0.841 0.159
E21.2 Other hyperparathyroidism
0.000 0.841 0.159
E23.0 Hypopituitarism
0.000 0.845 0.155
C95.7 Other leukaemia of unspecified cell type
0.004 0.848 0.148
C95.2 Subacute leukaemia of unspecified cell type
0.004 0.848 0.148
E25.9 Adrenogenital disorder, unspecified
0.000 0.849 0.151
E25.8 Other adrenogenital disorders
0.000 0.849 0.151
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.849 0.151
E30.9 Disorder of puberty, unspecified
0.000 0.849 0.151
E30.8 Other disorders of puberty
0.000 0.849 0.151
E30.1 Precocious puberty
0.000 0.849 0.151
E30.0 Delayed puberty
0.000 0.849 0.151
E31.9 Polyglandular dysfunction, unspecified
0.000 0.849 0.151
E31.8 Other polyglandular dysfunction
0.000 0.849 0.151
E31.1 Polyglandular hyperfunction
0.000 0.849 0.151
E31.0 Autoimmune polyglandular failure
0.000 0.849 0.151
E32.9 Disease of thymus, unspecified
0.000 0.849 0.151
E32.8 Other diseases of thymus
0.000 0.849 0.151
E32.1 Abscess of thymus
0.000 0.849 0.151
E32.0 Persistent hyperplasia of thymus
0.000 0.849 0.151

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.